We combine innovation and scientific research
Linari Medical was born in Italy in 2019 at the end of a 10-year clinical research conducted in collaboration with the Stella Maris Foundation in Pisa to develop a telemedicine technology for neurorehabilitation.
The result of the development is AvDesk, a CE-certified and internationally patented medical device for evaluation and treatment of visual and cognitive disorders, in adults and children.
A pioneer in this field, we have won prestigious awards such as Best Innovative Product awarded in 2011 by the Pisa Chamber of Commerce and Best Innovative Device-Technology at the 2019 Life Science Excellence Awards.
We were recognized by Microsoft among the top 40 startups in the world and Best Startup for Innovative Medical Devices at the 2019 Health Forum.
In 2022, we were chosen by the Digital Health program of VITA Accellerator, the national network of digital health accelerators of CDP Venture Capital, thus also being able to count on the support of Cassa Depositi e Prestiti to grow.
Since 2019 to date, we have treated more than 400 subjects, thanks in part to collaboration with major Italian clinics and hospitals and a national network of certified physicians and therapists.
The scientific results of more than 18 years of international research have been published in the most authoritative medical journals.
Research confirms the therapeutic value of AvDesk as a device capable of treating even so-called frontier diseases.
Over the years, major enhancement projects have emerged on sports subjects and for those in professions that require special visual performance, such as rescue teams, airline pilots, drivers, and the armed forces.
In collaboration with the Linari Group
Our team has precise skills and experience ranging from software and hardware design to production deployment and marketing.
Linari Group companies have been active worldwide in the development of highly innovative technologies for more than 20 years. Through collaboration with leading international research centers in the fields of medicine, nanotechnology and information technology.
Through innovation, we strive to promote inclusive access to treatments for visual defects.
